LeMaitre Vascular, Inc.

NasdaqGM:LMAT Rapporto sulle azioni

Cap. di mercato: US$2.3b

LeMaitre Vascular Performance dei guadagni passati

Il passato criteri di controllo 5/6

LeMaitre Vascular ha registrato una crescita degli utili a un tasso medio annuo di 13.3%, mentre il settore Medical Equipment ha registrato utili in crescita a un tasso medio annuo di 13.2%. I ricavi sono stati in crescita a un tasso medio annuo di 12.5%. Il ritorno sul capitale proprio di LeMaitre Vascular è 12.5% e ha margini netti di 19.4%.

Informazioni chiave

13.3%

Tasso di crescita degli utili

10.4%

Tasso di crescita dell'EPS

Medical Equipment Crescita del settore8.9%
Tasso di crescita dei ricavi12.5%
Rendimento del capitale proprio12.5%
Margine netto19.4%
Ultimo aggiornamento sui guadagni30 Sep 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

LeMaitre Vascular: The Market Is Catching On To This Dividend Growth Story

Nov 03

LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Nov 02
LeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Potentially Undervalued?

Oct 08
Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Potentially Undervalued?

Investors Met With Slowing Returns on Capital At LeMaitre Vascular (NASDAQ:LMAT)

Sep 17
Investors Met With Slowing Returns on Capital At LeMaitre Vascular (NASDAQ:LMAT)

LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Price In Tune With Earnings

Sep 04
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Price In Tune With Earnings

If EPS Growth Is Important To You, LeMaitre Vascular (NASDAQ:LMAT) Presents An Opportunity

Aug 22
If EPS Growth Is Important To You, LeMaitre Vascular (NASDAQ:LMAT) Presents An Opportunity

LeMaitre Vascular: A Small Cap With Best-In-Industry Growth

Jul 23

Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$85.0 Based On Its Intrinsic Value?

Jul 12
Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$85.0 Based On Its Intrinsic Value?

Is There Now An Opportunity In LeMaitre Vascular, Inc. (NASDAQ:LMAT)?

Jun 18
Is There Now An Opportunity In LeMaitre Vascular, Inc. (NASDAQ:LMAT)?

Return Trends At LeMaitre Vascular (NASDAQ:LMAT) Aren't Appealing

Jun 05
Return Trends At LeMaitre Vascular (NASDAQ:LMAT) Aren't Appealing

LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Popularity With Investors Is Clear

May 02
LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Popularity With Investors Is Clear

Is Now The Time To Put LeMaitre Vascular (NASDAQ:LMAT) On Your Watchlist?

Apr 04
Is Now The Time To Put LeMaitre Vascular (NASDAQ:LMAT) On Your Watchlist?

Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Feb 29
Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?

Jan 19
What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?

Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Paint A Concerning Picture

Oct 27
Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Paint A Concerning Picture

Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?

Oct 11
Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?

Does LeMaitre Vascular (NASDAQ:LMAT) Deserve A Spot On Your Watchlist?

Aug 30
Does LeMaitre Vascular (NASDAQ:LMAT) Deserve A Spot On Your Watchlist?

The Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Don't Inspire Confidence

Jul 06
The Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Don't Inspire Confidence

Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$62.3 Based On Its Intrinsic Value?

May 20
Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$62.3 Based On Its Intrinsic Value?

Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?

Mar 12
Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?

Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?

Oct 23
Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?

Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Oct 05
Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

LeMaitre Vascular (NASDAQ:LMAT) Could Be Struggling To Allocate Capital

Sep 13
LeMaitre Vascular (NASDAQ:LMAT) Could Be Struggling To Allocate Capital

LeMaitre Vascular: Reiterate Buy Thesis Following Strong Q2 Numbers

Sep 08

LeMaitre Vascular goes ex dividend tomorrow

Aug 23

Ripartizione dei ricavi e delle spese

Come LeMaitre Vascular guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

NasdaqGM:LMAT Ricavi, spese e utili (USD Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Sep 24213418016
30 Jun 24206387717
31 Mar 24200347517
31 Dec 23193307317
30 Sep 23186277016
30 Jun 23177256815
31 Mar 23169216514
31 Dec 22162216213
30 Sep 22160216013
30 Jun 22160225813
31 Mar 22158275512
31 Dec 21154275312
30 Sep 21152285111
30 Jun 21151294910
31 Mar 21135244610
31 Dec 20129214610
30 Sep 20122194710
30 Jun 20115164810
31 Mar 20119185010
31 Dec 1911718499
30 Sep 1911519489
30 Jun 1911118479
31 Mar 1910823469
31 Dec 1810623458
30 Sep 1810321447
30 Jun 1810422447
31 Mar 1810318437
31 Dec 1710117437
30 Sep 179815437
30 Jun 179614436
31 Mar 179312426
31 Dec 168911406
30 Sep 168611396
30 Jun 16829386
31 Mar 16799376
31 Dec 15788375
30 Sep 15767365
30 Jun 15746365
31 Mar 15735364
31 Dec 14704365
30 Sep 14703365
30 Jun 14673365
31 Mar 14652365
31 Dec 13643355

Guadagni di qualità: LMAT ha guadagni di alta qualità.

Margine di profitto in crescita: Gli attuali margini di profitto netti di LMAT (19.4%) LMAT sono più alti rispetto allo scorso anno (14.7%).


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di LMAT sono cresciuti del 13.3% all'anno negli ultimi 5 anni.

Accelerare la crescita: La crescita degli utili di LMAT nell'ultimo anno ( 51.5% ) supera la media quinquennale ( 13.3% all'anno).

Guadagni vs Settore: La crescita degli utili LMAT nell'ultimo anno ( 51.5% ) ha superato la percentuale del settore Medical Equipment 12.6%.


Rendimento del capitale proprio

ROE elevato: Il Return on Equity ( 12.5% ) di LMAT è considerato basso.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate